Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a ...
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
(RTTNews) - Abcam Plc (ABCM, ABC.L), a supplier of life science research tools, announced Monday that it has entered into a definitive agreement to acquire BioVision, Inc., a unit of Boai NKY Medical ...
(Sharecast News) - Abcam said on Monday that it has agreed to buy California-based BioVision for $340m. The deal, which is expected to be accretive to earnings from the first full year of ownership ...
2 August 2021, Cambridge, UK – Abcam plc ("Abcam", “the Company” or "the Group") (AIM LSE: ABC; Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that it has ...
BioVision started supplying Abcam in 2003, and the transaction represents a compelling strategic fit for Abcam. Abcam plans to fund the acquisition from existing cash resources and a partial drawdown ...
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results